J&J/Ethicon Begins Worldwide Withdrawal Of Vaginal Mesh Products
This article was originally published in The Gray Sheet
Executive Summary
Firm is stopping sales of four of its vaginal mesh products in the face of over 1,000 product liability lawsuits and FDA requirements for post-market safety and efficacy studies.
You may also be interested in...
Jury Awards $13.5 Million In J&J Pelvic Mesh Personal Injury Suit
Ethicon plans to appeal the verdict, which includes $10 million in punitive damages and $3.25 million in compensatory damages, but some observers speculate that the size of the award might encourage more settlements.
PMA Mandate Set For Pelvic Organ Prolapse Transvaginal Mesh
FDA issued final orders up-classifying surgical mesh for transvaginal repair of pelvic organ prolapse from class II to class III and calling for PMA standards, including clinical trial, animal studies, and materials testing data from new and existing manufacturers.
Jury Awards $12.5 Million In Damages In Ethicon Pelvic Mesh Case
The jury in the first pelvic mesh case to be heard in Philadelphia’s Court of Common Pleas found that Ethicon failed to warn physicians of the risks of Prolift Pelvic Mesh and that the mesh’s design was defective. It awarded the plaintiff $5.5 million in compensatory damages and $7 million in punitive damages. Ethicon plans to appeal.